Attached files
| file | filename |
|---|---|
| EX-23.1 - EX-23.1 - Timber Pharmaceuticals, Inc. | a2228403zex-23_1.htm |
| EX-4.3 - EX-4.3 - Timber Pharmaceuticals, Inc. | a2228403zex-4_3.htm |
| EX-10.13 - EX-10.13 - Timber Pharmaceuticals, Inc. | a2228403zex-10_13.htm |
| EX-31.1 - EX-31.1 - Timber Pharmaceuticals, Inc. | a2228403zex-31_1.htm |
| EX-31.2 - EX-31.2 - Timber Pharmaceuticals, Inc. | a2228403zex-31_2.htm |
| EX-21.1 - EX-21.1 - Timber Pharmaceuticals, Inc. | a2228403zex-21_1.htm |
| 10-K - 10-K - Timber Pharmaceuticals, Inc. | a2228403z10-k.htm |
QuickLinks -- Click here to rapidly navigate through this document
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of BioPharmX Corporation (the "Company") on Form 10-K for the fiscal year ended January 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, in the capacities and on the date indicated below, certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of their knowledge:
- 1.
- The
Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
- 2.
- The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date:
May 2, 2016
| /s/ JAMES PEKARSKY James Pekarsky Chief Executive Officer and Chairman of the Board of Directors (Principal Executive Officer) |
||
/s/ GREG KITCHENER Greg Kitchener Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002